ValiRx plc
(the 'Company')
Update to the Sale of Shares Agreement
The Company announces that it has agreed amended payment terms with Biofield Corp ('Biofield') for the payment of Eur 600,000 as consideration due to the Company following the disposal of 10 per cent. of the Company's holding in its subsidiary, ValiBio S.A.. Under the amended payment terms, the Company will receive monthly payments commencing from 1 June, 2009. The Company will receive an additional Eur 60,000 to compensate the Company for the delay in payment of the initial consideration.
For further information contact:
ValiRx plc |
Tel: +44 (0) 20 3008 4416 |
Dr. Satu Vainikka |
|
|
|
David Youngman / Adrian Kirk |
|
|
|
Sue Charles / Adrian Duffield / Justine Lamond |
valirx@collegehill.com |